These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2878 related items for PubMed ID: 16911497

  • 1. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B, Höcker B.
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [Abstract] [Full Text] [Related]

  • 2. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 3. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK, Wu FL, Lai IR, Lee CY, Hu RH, Lee PH.
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [Abstract] [Full Text] [Related]

  • 4. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B, Tönshoff B.
    Paediatr Drugs; 2011 Feb 01; 13(1):49-69. PubMed ID: 21162600
    [Abstract] [Full Text] [Related]

  • 5. Calcineurin-inhibitor-sparing immunosuppressive protocols.
    Bestard O, Cruzado JM, Grinyó JM.
    Transplant Proc; 2005 Nov 01; 37(9):3729-32. PubMed ID: 16386520
    [Abstract] [Full Text] [Related]

  • 6. SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity.
    Höcker B, Feneberg R, Köpf S, Weber LT, Waldherr R, Wühl E, Tönshoff B.
    Pediatr Transplant; 2006 Aug 01; 10(5):593-601. PubMed ID: 16856996
    [Abstract] [Full Text] [Related]

  • 7. The safety of calcineurin inhibitors for kidney-transplant patients.
    Malvezzi P, Rostaing L.
    Expert Opin Drug Saf; 2015 Oct 01; 14(10):1531-46. PubMed ID: 26329325
    [Abstract] [Full Text] [Related]

  • 8. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM, Kobashigawa J, Klintmalm G.
    Clin Transplant; 2008 Oct 01; 22(1):1-15. PubMed ID: 18217899
    [Abstract] [Full Text] [Related]

  • 9. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology.
    Stevens RB, Foster KW, Miles CD, Kalil AC, Florescu DF, Sandoz JP, Rigley TH, Malik T, Wrenshall LE.
    PLoS One; 2015 Oct 01; 10(10):e0139247. PubMed ID: 26465152
    [Abstract] [Full Text] [Related]

  • 10. Calcineurin inhibitor-free protocols: risks and benefits.
    Barbari AG, Stephan AG, Masri MA.
    Saudi J Kidney Dis Transpl; 2007 Mar 01; 18(1):1-23. PubMed ID: 17237886
    [Abstract] [Full Text] [Related]

  • 11. De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results.
    Guethoff S, Stroeh K, Grinninger C, Koenig MA, Kleinert EC, Rieger A, Mayr T, von Ziegler F, Reichart B, Hagl C, Schramm R, Kaczmarek I, Meiser BM.
    J Heart Lung Transplant; 2015 May 01; 34(5):634-42. PubMed ID: 25701373
    [Abstract] [Full Text] [Related]

  • 12. Calcineurin inhibitor sparing in renal transplantation.
    Ekberg H.
    Transplantation; 2008 Sep 27; 86(6):761-7. PubMed ID: 18813097
    [Abstract] [Full Text] [Related]

  • 13. Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial.
    Weir MR, Pearson TC, Patel A, Peddi VR, Kalil R, Scandling J, Chan L, Baliga P, Melton L, Mulgaonkar S, Waid T, Schaefer H, Youssef N, Anandagoda L, McCollum D, Lawson S, Gordon R.
    Transplantation; 2017 Jan 27; 101(1):157-165. PubMed ID: 26950714
    [Abstract] [Full Text] [Related]

  • 14. Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.
    Tredger JM, Brown NW, Dhawan A.
    Drugs; 2008 Jan 27; 68(10):1385-414. PubMed ID: 18578558
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 16. Calcineurin inhibitor minimization protocols in liver transplantation.
    Farkas SA, Schnitzbauer AA, Kirchner G, Obed A, Banas B, Schlitt HJ.
    Transpl Int; 2009 Jan 27; 22(1):49-60. PubMed ID: 19121146
    [Abstract] [Full Text] [Related]

  • 17. Minimizing calcineurin inhibitor drugs in renal transplantation.
    Flechner SM.
    Transplant Proc; 2003 May 27; 35(3 Suppl):118S-121S. PubMed ID: 12742481
    [Abstract] [Full Text] [Related]

  • 18. Belatacept for kidney transplant recipients.
    Masson P, Henderson L, Chapman JR, Craig JC, Webster AC.
    Cochrane Database Syst Rev; 2014 Nov 24; 2014(11):CD010699. PubMed ID: 25416857
    [Abstract] [Full Text] [Related]

  • 19. Can we eliminate both calcineurin inhibitors and steroids?
    Lebranchu Y.
    Transplant Proc; 2010 Nov 24; 42(9 Suppl):S25-8. PubMed ID: 21095446
    [Abstract] [Full Text] [Related]

  • 20. Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients.
    Mourer JS, de Koning EJ, van Zwet EW, Mallat MJ, Rabelink TJ, de Fijter JW.
    Transplantation; 2013 Jul 15; 96(1):49-57. PubMed ID: 23715049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 144.